Global Needle-Free Devices Market to Reach $27.7 Billion by 2030, Growing at a CAGR of 10.2% from 2025

The global needle-free devices market is projected to grow from $17.0 billion in 2025 to $27.7 billion by 2030, at a CAGR of 10.2%. Advancements in medical technology and consumer demand for patient-friendly treatment solutions are driving the market. Pharmaceutical companies are investing in developing needle-free solutions, which promise a more efficient and less painful drug delivery process. Key players include GSK, Novartis, Viatris, and PharmaJet.